Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
27.03.2024 - SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat ...
Karina Calzadilla About Adaptive Minimal Residual Disease Vice President Adaptive Biotechnologies Corporation Chart Daptive Biotechnologies Corporation Kurs
Source: wallstreet-online.de